stoxline Quote Chart Rank Option Currency Glossary
  
Jin Medical International Ltd. (ZJYL)
1.82  -0.41 (-18.39%)    06-30 16:00
Open: 2.19
High: 2.19
Volume: 46,536
  
Pre. Close: 2.23
Low: 1.82
Market Cap: 14(M)
Technical analysis
2026-06-30 4:19:00 PM
Short term     
Mid term     
Targets 6-month :  4.06 1-year :  5.25
Resists First :  3.47 Second :  4.5
Pivot price 2.34
Supports First :  1.82 Second :  1.51
MAs MA(5) :  2.21 MA(20) :  2.45
MA(100) :  2.41 MA(250) :  6.01
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  10 D(3) :  15.8
RSI RSI(14): 32
52-week High :  17.18 Low :  1.64
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ZJYL ] has closed below the lower bollinger band by 32.8%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ ZJYL ] is to continue within current trading range. Bollinger Bands are 10.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.35 - 2.36 2.36 - 2.37
Low: 2.15 - 2.17 2.17 - 2.18
Close: 2.21 - 2.23 2.23 - 2.25
Company Description

Jin Medical International Ltd. specializes in the conception, production, and worldwide distribution of mobility and daily living aids, including wheelchairs, for individuals with disabilities or restricted movement. Their product range additionally features oxygen concentrators and specialized bathing devices. Established in 2006, the company is headquartered in Changzhou, China, and operates as a subsidiary of Jolly Harmony Enterprises Limited.

Headline News

Tue, 30 Jun 2026
Massive share issuance and control shift at Jin Medical (ZJYL) with Tongsheng VIE deal - Stock Titan

Mon, 29 Jun 2026
Enterprise value to revenue forward of JIN MEDICAL INTERNATIONAL LTD. – NASDAQ:ZJYL - TradingView

Sun, 21 Jun 2026
JIN MEDICAL INTERNATIONAL (ZJYL) Edges Higher as Stock Approaches Key Resistance - Pullback Trade - dars.gov.et

Wed, 17 Jun 2026
Jin Medical International Ltd (ZJYL) Institutional Confidence - TradingKey

Wed, 17 Jun 2026
Jin Medical International Ltd (ZJYL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Thu, 04 Jun 2026
Jin Medical (ZJYL) appoints Enrome LLP as new independent auditor - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 7 (M)
Shares Float 39 (M)
Held by Insiders 86.9 (%)
Held by Institutions 0 (%)
Shares Short 19 (K)
Shares Short P.Month 13 (K)
Stock Financials
EPS 0.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.78
Profit Margin 5.7 %
Operating Margin 9.8 %
Return on Assets (ttm) 0.7 %
Return on Equity (ttm) 4.7 %
Qtrly Rev. Growth -16.5 %
Gross Profit (p.s.) 0.91
Sales Per Share 3.02
EBITDA (p.s.) 0.12
Qtrly Earnings Growth -32 %
Operating Cash Flow 3 (M)
Levered Free Cash Flow -5 (M)
Stock Valuations
PE Ratio 9.1
PEG Ratio 0
Price to Book value 0.48
Price to Sales 0.6
Price to Cash Flow 4.28
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android